"Carcinoma, Small Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
| Descriptor ID |
D018288
|
| MeSH Number(s) |
C04.557.470.200.380
|
| Concept/Terms |
Carcinoma, Small Cell- Carcinoma, Small Cell
- Carcinomas, Small Cell
- Small Cell Carcinomas
- Oat Cell Carcinoma
- Small Cell Carcinoma
- Carcinoma, Oat Cell
- Carcinomas, Oat Cell
- Oat Cell Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Small Cell".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Small Cell".
This graph shows the total number of publications written about "Carcinoma, Small Cell" by people in this website by year, and whether "Carcinoma, Small Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1996 | 2 | 0 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 2 | 0 | 2 |
| 2000 | 3 | 0 | 3 |
| 2001 | 0 | 2 | 2 |
| 2002 | 3 | 1 | 4 |
| 2003 | 2 | 0 | 2 |
| 2004 | 4 | 0 | 4 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Small Cell" by people in Profiles.
-
Kuan EC, Alonso JE, Tajudeen BA, Arshi A, Mallen-St Clair J, St John MA. Small cell carcinoma of the head and neck: A comparative study by primary site based on population data. Laryngoscope. 2017 08; 127(8):1785-1790.
-
Miettinen M, Wang Z, Lasota J, Heery C, Schlom J, Palena C. Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases. Am J Surg Pathol. 2015 Oct; 39(10):1305-12.
-
Lee JJ, Vrabec TR, Baldassano VF. Cancer-associated retinopathy with unusual retinal whitening. Retin Cases Brief Rep. 2015; 9(1):21-4.
-
Shah SU, Mashayekhi A, Shields CL, Walia HS, Hubbard GB, Zhang J, Shields JA. Uveal metastasis from lung cancer: clinical features, treatment, and outcome in 194 patients. Ophthalmology. 2014 Jan; 121(1):352-357.
-
Fiorentino FP, Macaluso M, Miranda F, Montanari M, Russo A, Bagella L, Giordano A. CTCF and BORIS regulate Rb2/p130 gene transcription: a novel mechanism and a new paradigm for understanding the biology of lung cancer. Mol Cancer Res. 2011 Feb; 9(2):225-33.
-
Chen J, Emara N, Solomides C, Parekh H, Simpkins H. Resistance to platinum-based chemotherapy in lung cancer cell lines. Cancer Chemother Pharmacol. 2010 Nov; 66(6):1103-11.
-
Crisanti MC, Wallace AF, Kapoor V, Vandermeers F, Dowling ML, Pereira LP, Coleman K, Campling BG, Fridlender ZG, Kao GD, Albelda SM. The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer. Mol Cancer Ther. 2009 Aug; 8(8):2221-31.
-
Witt RL, Wilson PA. Vocal fold immobility from a primary minor salivary gland small-cell carcinoma: case report. Ear Nose Throat J. 2009 Feb; 88(2):E13-6.
-
Rudin CM, Salgia R, Wang X, Hodgson LD, Masters GA, Green M, Vokes EE. Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103. J Clin Oncol. 2008 Feb 20; 26(6):870-6.
-
Kut V, Spies W, Spies S, Gooding W, Argiris A. Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET). Am J Clin Oncol. 2007 Feb; 30(1):45-50.